Medical devices, healthcare technology and the business of care
510(k) clearance · K262230

Mg OSTEOREVIVE;Mg OSTEOCRETE

Bone Solutions, Inc. · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONK262230

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-11 for K262230, submitted 06/30/2026 by Bone Solutions, Inc. of Colleyville, Texas, through correspondent PaxMed International, LLC. The device is listed as Mg OSTEOREVIVE™;Mg OSTEOCRETE™, under regulation 888.3045 in the classification Filler, Bone Void, Calcium Compound, product code MQV with subsequent codes MBP and OIS. The review panel and medical specialty are both orthopedic, and the submission was a traditional 510(k) not reviewed by a third party.

SESE in the 510(k) pathway means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record does not identify which predicate was cited, which component or formulation change was the subject of the submission, or the specific indications, materials and instructions for use, so those details remain unknown from this page. The record also lists no combination product status and no authorized predetermined change control plan.

The page was last updated 11/02/2026 and carries no summary statement text in the supplied data, so any clinical performance or labeling claims would require the underlying FDA documents rather than this listing.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 11, 2026
FDA decision documents: 510 (k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262230
Regulatory pathway
510(k) premarket notification
Product code
MQV
Decision code
SESE
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, Bone Void, Calcium Compound.

Product code
MQV
FDA device class
2

FDA decision timeline

  1. K262230 received

    Application receipt date recorded by FDA.

  2. K262230 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MQV

Product / regulatory recordCompanyPathwayDecision dateSource
Marine Biomedical510(k) clearanceNov 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bone Solutions, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Colleyville, TX

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records